Home » Topics » Regulatory

Regulatory
RSS

Granocyte granted expanded marketing authorization

July 7, 1998

Scientifically tested hair loss treatment introduced in Canada

July 1, 1998

Broadened use of Taxotere in breast cancer cleared by FDA

June 25, 1998

FDA approves biotech product for RSV disease in children

June 22, 1998

SangStat receives U.S. patent covering multiple ciclosporin formulations

June 19, 1998

Famvir cleared by FDA for treatment of herpes in HIV-positive individuals

June 18, 1998

Topical antiinflammatory corticosteroid approved for marketing in Japan

June 17, 1998

AmBisome label expanded in Spain

June 15, 1998

Anesta signs Actiq partnership with Lafon

June 10, 1998

U.K. launch of Zoladex for assisted conception

June 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...